ArticleFrontiers in immunology2023

Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab.

Elina Groß-Albenhausen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.